No. Pulmonary hypertension and systemic arterial hypertension are two different conditions. Commonly called "high blood pressure", systemic hypertension concerns the pressure of blood in the arteries that carry it from the left side of the heart to the rest of the body; this is the pressure measured with an arm cuff. Pulmonary hypertension instead concerns pressure in the circulation that carries blood from the right ventricle to the lungs.
Their values, the tests used to measure them, their causes and their treatments are therefore not interchangeable.
Confusion is especially common when an echocardiogram report includes wording such as "increased pulmonary arterial pressure" or a PAPs value expressed in mmHg. The fact that both pressures are expressed in the same unit does not mean they can be directly compared.
The main points to understand are:
The heart functions as two connected pumps. The left ventricle sends oxygenated blood into the aorta and systemic circulation, which supplies the brain, kidneys, muscles and all other organs. The pressure measured at the arm belongs to this circuit.
The right ventricle, by contrast, receives venous blood and pumps it into the pulmonary arteries toward the lungs, where oxygen and carbon dioxide are exchanged.
The normal pulmonary circulation operates at much lower pressures than the systemic circulation. It is designed to accommodate the entire cardiac output while offering low resistance. Therefore, even increases in pressure that might appear modest compared with arm blood pressure can be significant in the pulmonary circulation.
The term pulmonary hypertension is defined hemodynamically by a mean pulmonary arterial pressure greater than 20 mmHg at rest, measured by right heart catheterization. This definition is in no way equivalent to the threshold used to diagnose systemic arterial hypertension.
According to the 2024 ESC guidelines, systemic arterial hypertension remains defined by an office blood pressure of at least 140/90 mmHg, normally confirmed by repeated or out-of-office measurements. The first number is systolic pressure and the second is diastolic pressure in the systemic circulation.
For pulmonary hypertension, the key diagnostic parameter is instead mean pulmonary arterial pressure, or mPAP, measured directly during right heart catheterization. The current threshold is an mPAP greater than 20 mmHg. Pulmonary artery wedge pressure and pulmonary vascular resistance are also considered to distinguish the different types of pulmonary hypertension.
An echocardiogram may report PAPs, an estimate of systolic pulmonary arterial pressure. This value is not the mPAP obtained by catheterization and must not be compared with systolic arm blood pressure. A PAPs of 40 mmHg, for example, is in no way equivalent to a systemic pressure of 140 mmHg and, on its own, cannot establish the diagnosis or severity of the disease.
Echocardiography is mainly used to estimate the probability of pulmonary hypertension based on tricuspid regurgitation velocity and other cardiac signs. When hemodynamic confirmation is required, right heart catheterization remains the reference standard.
Systemic arterial hypertension is very common and often causes no symptoms for years. Its principal concern is the progressive damage that elevated pressure can cause to the heart, brain, kidneys and arteries, increasing the risk of stroke, myocardial infarction, heart failure and kidney disease.
Pulmonary hypertension is much less common and more often presents with shortness of breath on exertion, fatigue, reduced exercise capacity, dizziness or syncope. In more advanced stages, leg edema, abdominal congestion and other signs of right ventricular failure may occur.
These symptoms are nonspecific and may be due to many other diseases, which is why diagnosis requires a structured assessment.
The main cardiac chamber exposed to increased workload also differs. In systemic hypertension, the left ventricle must pump against high pressure. In pulmonary hypertension, the right ventricle must work against increased resistance or pressure in the pulmonary circulation.
Being different diseases does not mean they cannot coexist. A person may have both systemic arterial hypertension and pulmonary hypertension. In addition, persistently elevated systemic blood pressure over many years can contribute to hypertensive heart disease, left ventricular hypertrophy, diastolic dysfunction or heart failure.
When left heart filling pressures increase, the rise may be transmitted backward to the pulmonary veins and capillaries. This can lead to pulmonary hypertension due to left heart disease, which belongs to group 2 of the pulmonary hypertension classification.
However, this association is indirect. Not everyone with arterial hypertension develops pulmonary hypertension, and a diagnosis of pulmonary hypertension does not mean that blood pressure measured at the arm is elevated. A person can have normal or even low systemic blood pressure while also having severe pulmonary vascular disease.
Systemic arterial hypertension is treated through lifestyle interventions and, when indicated, antihypertensive medications such as ACE inhibitors, angiotensin receptor blockers, calcium channel blockers, diuretics and other classes selected according to the patient's profile. The goal is to reduce systemic pressure and overall cardiovascular risk.
There is no single treatment for pulmonary hypertension. Management depends on the clinical group: left heart disease, lung diseases and hypoxia, chronic thromboembolic forms, pulmonary arterial hypertension or other conditions. In PAH, specific medications target biological pathways within the pulmonary circulation; in CTEPH, mechanical procedures may be necessary; in forms due to left heart disease, the priority is to treat the underlying cardiac condition.
For this reason, systemic antihypertensive treatment should not be changed with the aim of "lowering the PAPs" reported on an echocardiogram. Likewise, medications specific to PAH are not treatments for ordinary high blood pressure and must not be used without an appropriate diagnosis.
Are pulmonary hypertension and arterial hypertension the same disease?
No. Arterial hypertension concerns pressure in the arteries of the systemic circulation, which is measured at the arm. Pulmonary hypertension instead concerns the circulation that carries blood from the right side of the heart to the lungs.
Can pulmonary pressure be measured with an ordinary arm blood pressure monitor?
No. A sphygmomanometer measures systemic arterial blood pressure. Pulmonary pressure is estimated using tests such as echocardiography and, when necessary, measured directly by right heart catheterization.
Does a PAPs of 40 mmHg correspond to an arterial blood pressure of 140 mmHg?
No. These measurements refer to different circulations and must not be compared numerically. Moreover, echocardiographic PAPs is an estimate and is not the mean pressure used to define pulmonary hypertension hemodynamically.
Can high blood pressure cause pulmonary hypertension?
It can contribute indirectly if, over time, it promotes left heart disease, for example ventricular dysfunction or increased filling pressures. However, this does not mean that everyone with arterial hypertension automatically has pulmonary hypertension.
Do medications for high blood pressure also treat pulmonary hypertension?
Not automatically. Treatment for pulmonary hypertension depends on its cause and may be entirely different from treatment for systemic arterial hypertension.
Informational notice: the information contained on this page is provided solely for informational and educational purposes and does not replace the advice, diagnosis or treatment provided by a physician. If needed, always consult a qualified healthcare professional.
Artificial intelligence transparency: this page was created with the support of artificial intelligence tools, used to assist in the production and processing of its content.